Arrieta, Francisco, et al. “Therapeutic Approach With PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes”. Cardiology and Cardiovascular Medicine, vol. 4, no. 6, Dec. 2020, pp. 736-42, http://www.fortunejournals.org/ojs/index.php/ccm/article/view/15983.